{"entity":{"type":"insider","cik":"0001410081","url":"/insider/0001410081","json_url":"/insider/0001410081.json","name":"Najafi Ramin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":21,"first":"2008-03-18","last":"2015-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Najafi Ramin","source":"filing","n_filings":21,"first_seen":"2008-03-18","last_seen":"2015-08-21"}],"transactions":[{"id":8194687,"accession":"0001437749-15-016273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-15-016273","line_url":"/filing/0001437749-15-016273#line-2","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.44,"price_display":"0.44","price_state":"stated","total_value":2640.0,"total_display":"2,640.00","total_whole":"2,640","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-20","filed_date":"2015-08-21","scope":"insider"},{"id":8194686,"accession":"0001437749-15-016273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-15-016273","line_url":"/filing/0001437749-15-016273#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-21","scope":"insider"},{"id":8154945,"accession":"0001437749-15-004220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-15-004220","line_url":"/filing/0001437749-15-004220#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166666.0,"shares_display":"166,666","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":99999.6,"total_display":"99,999.60","total_whole":"100,000","shares_owned_after":3391666.0,"shares_owned_after_display":"3,391,666","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-03","filed_date":"2015-03-05","scope":"insider"},{"id":6760450,"accession":"0001437749-14-022088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-14-022088","line_url":"/filing/0001437749-14-022088#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":32500.0,"total_display":"32,500.00","total_whole":"32,500","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-15","scope":"insider"},{"id":6920995,"accession":"0001437749-14-021964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-14-021964","line_url":"/filing/0001437749-14-021964#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":3175000.0,"shares_owned_after_display":"3,175,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6270178,"accession":"0001437749-14-021787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-14-021787","line_url":"/filing/0001437749-14-021787#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":16250.0,"total_display":"16,250.00","total_whole":"16,250","shares_owned_after":3155000.0,"shares_owned_after_display":"3,155,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-05","filed_date":"2014-12-08","scope":"insider"},{"id":6327052,"accession":"0001437749-14-021674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-14-021674","line_url":"/filing/0001437749-14-021674#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":12780.0,"total_display":"12,780.00","total_whole":"12,780","shares_owned_after":3130000.0,"shares_owned_after_display":"3,130,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-04","scope":"insider"},{"id":3145048,"accession":"0001437749-12-012726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-12-012726","line_url":"/filing/0001437749-12-012726#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":24800.0,"total_display":"24,800.00","total_whole":"24,800","shares_owned_after":100195.0,"shares_owned_after_display":"100,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-06","filed_date":"2012-12-10","scope":"insider"},{"id":2433432,"accession":"0001437749-12-005628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-12-005628","line_url":"/filing/0001437749-12-005628","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.9593333333333334,"price_display":"0.96","price_state":"stated","total_value":5756.0,"total_display":"5,756.00","total_whole":"5,756","shares_owned_after":32752.0,"shares_owned_after_display":"32,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-30","scope":"insider","n_lines":2},{"id":2632585,"accession":"0001437749-12-005573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-12-005573","line_url":"/filing/0001437749-12-005573#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":3465.0,"total_display":"3,465.00","total_whole":"3,465","shares_owned_after":28752.0,"shares_owned_after_display":"28,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-25","filed_date":"2012-05-29","scope":"insider"},{"id":9038941,"accession":"0001437749-11-006130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-11-006130","line_url":"/filing/0001437749-11-006130#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Family Trust dated September 13, 2006; Najafi Ramin","owner_display_name":"Najafi Family Trust dated September 13, 2006","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":8500.0,"total_display":"8,500.00","total_whole":"8,500","shares_owned_after":25252.0,"shares_owned_after_display":"25,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-16","filed_date":"2011-08-16","scope":"insider"},{"id":9005516,"accession":"0001437749-11-003712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-11-003712","line_url":"/filing/0001437749-11-003712#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.5945,"price_display":"1.59","price_state":"stated","total_value":797.25,"total_display":"797.25","total_whole":"797","shares_owned_after":15252.0,"shares_owned_after_display":"15,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-05-31","scope":"insider"},{"id":8990394,"accession":"0001437749-11-003654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-11-003654","line_url":"/filing/0001437749-11-003654","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.5971,"price_display":"1.60","price_state":"stated","total_value":1597.1,"total_display":"1,597.10","total_whole":"1,597","shares_owned_after":14252.0,"shares_owned_after_display":"14,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-27","scope":"insider","n_lines":2},{"id":9184786,"accession":"0001437749-11-003623","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001437749-11-003623","line_url":"/filing/0001437749-11-003623","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2552.0,"shares_display":"2,552","price_per_share":1.7126457680250784,"price_display":"1.71","price_state":"stated","total_value":4370.672,"total_display":"4,370.67","total_whole":"4,371","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-24","filed_date":"2011-05-26","scope":"insider","n_lines":5},{"id":9230912,"accession":"0001140361-09-019948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-019948","line_url":"/filing/0001140361-09-019948#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":"0001410081","owner_name":"Najafi Ramin","owner_display_name":"Najafi Ramin","owner_url":"/insider/0001410081","role":"Director, Officer (Chief Executive Officer), Other","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":1920.0,"total_display":"1,920.00","total_whole":"1,920","shares_owned_after":11200.0,"shares_owned_after_display":"11,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-28","filed_date":"2009-08-28","scope":"insider"},{"id":3852343,"accession":"0001140361-08-027666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-027666","line_url":"/filing/0001140361-08-027666#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Ramin; Najafi Family Trust dated September 13, 2006","owner_display_name":"Najafi Ramin","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":570.0,"total_display":"570.00","total_whole":"570","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-10","filed_date":"2008-12-11","scope":"insider"},{"id":4145060,"accession":"0001140361-08-021242","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-08-021242","line_url":"/filing/0001140361-08-021242","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Ramin; Najafi Family Trust dated September 13, 2006","owner_display_name":"Najafi Ramin","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.858,"price_display":"1.86","price_state":"stated","total_value":929.0,"total_display":"929.00","total_whole":"929","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-12","filed_date":"2008-09-12","scope":"insider","n_lines":3},{"id":4145045,"accession":"0001140361-08-021242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-08-021242","line_url":"/filing/0001140361-08-021242","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Ramin; Najafi Family Trust dated September 13, 2006","owner_display_name":"Najafi Ramin","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.9224,"price_display":"1.92","price_state":"stated","total_value":1922.4,"total_display":"1,922.40","total_whole":"1,922","shares_owned_after":7900.0,"shares_owned_after_display":"7,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-11","filed_date":"2008-09-12","scope":"insider","n_lines":2},{"id":9287804,"accession":"0001437749-11-000574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-11-000574","line_url":"/filing/0001437749-11-000574#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Family Trust dated September 13, 2006; Najafi Ramin","owner_display_name":"Najafi Family Trust dated September 13, 2006","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":1980.0,"total_display":"1,980.00","total_whole":"1,980","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2011-02-01","scope":"insider"},{"id":3483454,"accession":"0001140361-08-020592","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-08-020592","line_url":"/filing/0001140361-08-020592#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Family Trust dated September 13, 2006; Najafi Ramin","owner_display_name":"Najafi Family Trust dated September 13, 2006","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":1980.0,"total_display":"1,980.00","total_whole":"1,980","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":5699125,"accession":"0001140361-09-019947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-09-019947","line_url":"/filing/0001140361-09-019947#line-1","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Family Trust dated September 13, 2006; Najafi Ramin","owner_display_name":"Najafi Family Trust dated September 13, 2006","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":1920.0,"total_display":"1,920.00","total_whole":"1,920","shares_owned_after":11200.0,"shares_owned_after_display":"11,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2009-08-28","scope":"insider"},{"id":3615455,"accession":"0001181431-08-049373","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-08-049373","line_url":"/filing/0001181431-08-049373#line-3","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Ramin; Najafi Family Trust dated September 13, 2006","owner_display_name":"Najafi Ramin","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":1182.0,"total_display":"1,182.00","total_whole":"1,182","shares_owned_after":6200.0,"shares_owned_after_display":"6,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-20","filed_date":"2008-08-20","scope":"insider"},{"id":3615454,"accession":"0001181431-08-049373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-049373","line_url":"/filing/0001181431-08-049373","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Ramin; Najafi Family Trust dated September 13, 2006","owner_display_name":"Najafi Ramin","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.015,"price_display":"2.02","price_state":"stated","total_value":4030.0,"total_display":"4,030.00","total_whole":"4,030","shares_owned_after":5600.0,"shares_owned_after_display":"5,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-19","filed_date":"2008-08-20","scope":"insider","n_lines":2},{"id":3790345,"accession":"0001181431-08-019649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-08-019649","line_url":"/filing/0001181431-08-019649","is_derivative":false,"issuer_cik":"0001389545","issuer_name":"NovaBay Pharmaceuticals, Inc.","issuer_ticker":"NBY","issuer_name_source":null,"issuer_url":"/issuer/0001389545","owner_cik":null,"owner_name":"Najafi Family Trust dated September 13, 2006; Najafi Ramin","owner_display_name":"Najafi Family Trust dated September 13, 2006","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3600.0,"shares_display":"3,600","price_per_share":2.713888888888889,"price_display":"2.71","price_state":"stated","total_value":9770.0,"total_display":"9,770.00","total_whole":"9,770","shares_owned_after":3600.0,"shares_owned_after_display":"3,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-18","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001389545","name":"NovaBay Pharmaceuticals, Inc.","url":"/issuer/0001389545","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","n_filings":21,"first_seen":"2008-03-18","last_seen":"2015-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410081","retrieved_at":"2026-08-24T12:53:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}